JP2014511827A5 - - Google Patents

Download PDF

Info

Publication number
JP2014511827A5
JP2014511827A5 JP2013558271A JP2013558271A JP2014511827A5 JP 2014511827 A5 JP2014511827 A5 JP 2014511827A5 JP 2013558271 A JP2013558271 A JP 2013558271A JP 2013558271 A JP2013558271 A JP 2013558271A JP 2014511827 A5 JP2014511827 A5 JP 2014511827A5
Authority
JP
Japan
Prior art keywords
derived
pharmaceutical composition
adipose tissue
composition according
acne
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013558271A
Other languages
English (en)
Japanese (ja)
Other versions
JP6038821B2 (ja
JP2014511827A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/AU2012/000274 external-priority patent/WO2012122604A1/en
Publication of JP2014511827A publication Critical patent/JP2014511827A/ja
Publication of JP2014511827A5 publication Critical patent/JP2014511827A5/ja
Application granted granted Critical
Publication of JP6038821B2 publication Critical patent/JP6038821B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013558271A 2011-03-15 2012-03-15 医薬組成物およびその局所使用 Expired - Fee Related JP6038821B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
AU2011900932A AU2011900932A0 (en) 2011-03-15 Pharmaceutical compositions and topical use thereof
AU2011900932 2011-03-15
AU2012900140 2012-01-13
AU2012900140A AU2012900140A0 (en) 2012-01-13 Pharmaceutical compositions and topical use thereof
PCT/AU2012/000274 WO2012122604A1 (en) 2011-03-15 2012-03-15 Pharmaceutical compositions and topical use thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2016215032A Division JP2017031214A (ja) 2011-03-15 2016-11-02 医薬組成物およびその局所使用

Publications (3)

Publication Number Publication Date
JP2014511827A JP2014511827A (ja) 2014-05-19
JP2014511827A5 true JP2014511827A5 (cg-RX-API-DMAC7.html) 2015-08-13
JP6038821B2 JP6038821B2 (ja) 2016-12-07

Family

ID=46829963

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2013558271A Expired - Fee Related JP6038821B2 (ja) 2011-03-15 2012-03-15 医薬組成物およびその局所使用
JP2016215032A Pending JP2017031214A (ja) 2011-03-15 2016-11-02 医薬組成物およびその局所使用
JP2018013476A Expired - Fee Related JP6621853B2 (ja) 2011-03-15 2018-01-30 医薬組成物およびその局所使用

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2016215032A Pending JP2017031214A (ja) 2011-03-15 2016-11-02 医薬組成物およびその局所使用
JP2018013476A Expired - Fee Related JP6621853B2 (ja) 2011-03-15 2018-01-30 医薬組成物およびその局所使用

Country Status (8)

Country Link
US (2) US9730964B2 (cg-RX-API-DMAC7.html)
EP (2) EP2685993B9 (cg-RX-API-DMAC7.html)
JP (3) JP6038821B2 (cg-RX-API-DMAC7.html)
CN (2) CN103596577B (cg-RX-API-DMAC7.html)
AU (1) AU2012229890B2 (cg-RX-API-DMAC7.html)
CA (1) CA2865652C (cg-RX-API-DMAC7.html)
DK (1) DK3156060T3 (cg-RX-API-DMAC7.html)
WO (1) WO2012122604A1 (cg-RX-API-DMAC7.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG10201606745XA (en) * 2011-09-23 2016-10-28 Cell Ideas Pty Ltd Therapeutics using adipose cells and cell secretions
JP2023002772A (ja) * 2011-09-23 2023-01-10 レジニアス リミテッド 脂肪細胞および細胞分泌物を使用する治療
US20160220479A1 (en) * 2013-09-12 2016-08-04 Ohio State Innovation Foundation Topical compounds containing adipose-derived hormones for the rejuvenation of skin
WO2016013352A1 (ja) * 2014-07-23 2016-01-28 学校法人日本大学 脱分化脂肪細胞の製造方法
IT201700102994A1 (it) * 2017-09-14 2019-03-14 Genlife Sagl Catalizzatore rigenerativo di tessuti e relativo procedimento di realizzazione
KR20230117627A (ko) 2017-10-02 2023-08-08 히로타로 후쿠오카 두피 혹은 피부의 개질, 창상 치유, 또는 모발의 개질에이용되기 위한 의약 조성물
KR102649069B1 (ko) * 2018-05-31 2024-03-19 주식회사 엑소코바이오 줄기세포 유래의 엑소좀을 유효성분으로 포함하는 안면 홍조 개선용 조성물
WO2024151321A2 (en) * 2022-08-05 2024-07-18 Trustees Of Tufts College Systems and methods for commercial scale cultured adipose tissue production
DE202023002794U1 (de) 2022-12-27 2024-07-15 AVITA Medical Americas, LLC Kassette zur Herstellung einer regenerativen epidermalen Suspension
US12570949B2 (en) 2022-12-27 2026-03-10 AVITA Medical Americas, LLC Systems and devices for wound therapy and related methods of use
USD1112812S1 (en) 2023-12-22 2026-02-10 AVITA Medical Americas, LLC Tissue processing cartridge

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4296099A (en) * 1976-11-30 1981-10-20 L'oreal Process for extracting embryonic calf skin and pharmaceutical compositions containing the same
US5762947A (en) * 1997-05-09 1998-06-09 Elizabeth Arden Co., Division Of Conopco, Inc. Cosmetic skin conditioning compositions containing a salicyloxy α-carboxy acid
RU2306335C2 (ru) * 1999-03-10 2007-09-20 Юниверсити Оф Питтсбург Оф Дзе Коммонвелт Систем Оф Хайер Эдьюкейшн Стволовые клетки и решетки, полученные из жировой ткани
IT1309453B1 (it) * 1999-10-01 2002-01-23 Consorzio Per Gli Studi Uni Substrato bioartificiale per la realizzazione di tessuti e organianimali, in particolare umani.
AU2002360788A1 (en) 2001-12-31 2003-07-24 Isolagen Technologies, Inc. Hair follicle growth
ES2375565T3 (es) * 2003-08-07 2012-03-02 Healor Ltd. Composiciones farmacéuticas y métodos para acelerar la cicatrización de heridas.
AU2004280616A1 (en) 2003-10-08 2005-04-21 Vet-Stem Inc. Methods of preparing and using stem cell compositions and kits comprising the same
WO2007026356A2 (en) * 2005-08-29 2007-03-08 Healor Ltd. Methods and compositions for prevention and treatment of diabetic and aged skin
FR2894961B1 (fr) * 2005-12-16 2008-05-16 Oreal Utilisation de ceramides pour depigmenter la peau
CN101400787B (zh) * 2006-01-27 2013-01-23 株式会社Prostemics 采用脂肪来源成体干细胞大量制造生长因子的方法
US20100092432A1 (en) * 2006-08-08 2010-04-15 Takenori Ozaki Cell preparation containing multipotential stem cells originating in fat tissue
AU2007320031B2 (en) * 2006-10-06 2013-05-02 University Of Virginia Patent Foundation Methods and compositions useful for diabetic wound healing
KR101220239B1 (ko) * 2008-04-01 2013-01-09 바이오스펙트럼 주식회사 식물성 펩톤을 포함하는 줄기세포 증식 촉진용 조성물
KR100994133B1 (ko) 2008-04-15 2010-11-15 송신혜 문양이 삽입된 유리 제품 및 이의 제조 방법
FR2938334A1 (fr) 2008-11-13 2010-05-14 Galderma Res & Dev Modulateurs de l'adfp dans le traitement de l'acne, d'une dermatite seborrheique ou de l'hyperseborrhee
AU2009201915C1 (en) 2008-08-22 2015-02-26 Regeneus Ltd Therapeutic methods
WO2011043136A1 (ja) 2009-10-08 2011-04-14 国立大学法人名古屋大学 脂肪組織由来間葉系幹細胞を含有する免疫抑制剤及びその用途
AU2009251017A1 (en) * 2009-12-17 2011-07-07 Regeneus Ltd. Therapeutic methods
KR100995133B1 (ko) * 2010-02-10 2010-11-18 허쉬바이오주식회사 지방조직 유래 줄기세포 및 단핵구로부터 세포성장인자의 생산방법 및 그 이용
KR101749218B1 (ko) 2010-04-26 2017-06-20 (주)프로스테믹스 양모 효과를 가지는 인간 지방유래 줄기세포의 조건 배지 및 이의 용도
US20120195969A1 (en) * 2010-09-29 2012-08-02 Aidan Research And Consulting, Llc Treatment of acne by conditioned media

Similar Documents

Publication Publication Date Title
WO2014145958A3 (en) Network-based microbial compositions and methods
WO2014153115A3 (en) Compositions and methods for reprogramming hematopoietic stem cell lineages
NZ611606A (en) Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity
CA2840307C (en) Progenitor cells of mesodermal lineage
WO2012056457A3 (en) Compositions and methods for activating expression by a specific endogenous mirna
PL2444081T3 (pl) Kompozycja do leczenia chorób zapalnych, zawierająca kwas bosweliowy i kannabidiol
BR112014010650A2 (pt) inoculantes microbianos e composições fertilizantes que compreendem os mesmos
EP3409666A3 (en) Seca inhibitors and methods of making and using thereof
EP2558478A4 (en) AT 5 POSITIONS MODIFIED PYRIMIDINES AND THEIR USE
CL2012003723A1 (es) Compuestos derivados de acido 2-quinolinil-acetico; composicion farmaceutica; y uso en el tratamiento del vih y sida.
MX2013005549A (es) Aminas heterociclicas y sus usos.
AR090339A1 (es) Metodos de pronostico, diagnostico y tratamiento de la fibrosis pulmonar idiopatica
EP2830646A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF METABOLISM DISEASES
CL2013000238A1 (es) Uso de inhibores de la succinato deshidrogenasa y/o inhibidores del complejo iii para mejorar la relacion entre microorganismos dañinos y beneficiosos.
IN2015DN00934A (cg-RX-API-DMAC7.html)
EP3943092A3 (en) Compositions for use in inducing differentiation of human brown adipocyte progenitors
IL232515A0 (en) nadph 4 oxidase inhibitors and pharmaceutical preparations containing them
SI2575971T1 (sl) Kombinirani rastlinski izvlečki za uporabo pri zdravljenju okužb z mikrobi
EP2685993B8 (en) Composition adipose tissue-derived secretions for use in the topical treatment or prevention of acne
HK1205952A1 (en) Modulators of acyl-coa lysocardiolipin acyltransferase 1 ( alcat1) and uses thereof
EP3052191A4 (en) Directed differentiation of astrocytes from human pluripotent stem cells for use in drug screening and the treatment of amyotrophic lateral sclerosis (als)
PL2613798T3 (pl) Zastosowanie lizosomalnej kwaśnej lipazy do leczenia niedoboru lizosomalnej kwaśnej lipazy u pacjentów
FR2981072B1 (fr) Compose sensible au ph, utilisation, composition et procede de traitement le mettant en œuvre
EP2854826A4 (en) SELECTION AND USE OF MILK ACID BACTERIA FOR PREVENTING BONE REMOVAL IN MAMMALS
PH12014501240A1 (en) Film containing compositions